Lv4
490 积分 2020-06-16 加入
Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
13小时前
已完结
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
13小时前
已完结
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
13小时前
已完结
Heart Failure with Preserved Ejection Fraction
14小时前
已完结
Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure
24天前
已完结
The causal association between lipid-lowering strategies and risk of intracranial aneurysms: a drug-target Mendelian randomization study
1个月前
已完结
Impact of PCSK9 inhibitors on bleeding and adverse outcomes in post-PCI patients undergoing antiplatelet therapy: A real-world cohort study
2个月前
已完结
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
2个月前
已关闭
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose‐lowering therapy: A pre‐specified analysis of the DELIVER trial
2个月前
已完结
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
2个月前
已完结
皖公网安备34019202002308
